跳转至内容
Merck
CN

AST1002

Astrocytes, Mature, CTRL Line

IPSC derived

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352200
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

biological source

human

growth mode

Adherent

karyotype

2n=46

morphology

elongated, flat, astrocytic

shipped in

dry ice

storage temp.

−196°C

Application

These products provide unique and versatile tools for the study of central nervous system (CNS) disorders, such as Alzheimer′s disease (AD), Parkinson′s disease (PD), autism, schizophrenia, and amyotrophic lateral sclerosis (ALS), as well as for drug screening and toxicology applications in the neural space.

Biochem/physiol Actions

Control line, derived from integration free made iPSC line, mature astrocytes

Features and Benefits

This product contains cryo-preserved, pre-differentiated astrocytes derived from a footprint-free, karyotype normal human iPSC line. It was designed for customers to generate mature astrocytes using the optimized maturation medium and supplements (AST1050, AST1051 sold separately). Mature astrocytes can be obtained within 17 days. Shortly after seeding and recovery, the cells proliferate and need to be passaged a minimum of two times. In general, at 17 days post-seeding, the cell population will contain ≥80% Glial Fibrillary Acidic Protein (GFAP) positive astrocytes and ≤15% Tuj-1 positive neurons (neuronal class III β-tubulin).

Preparation Note

The cells need to be passaged a minimum of two times. See technical bulletin for additional details.
User must also purchase Astrocyte Maturation Medium, AST1050 (50mL) or AST1051 (250mL). Sold separately.

存储类别

10 - Combustible liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

法规信息

新产品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our 文件 section.

如需帮助,请联系 客户支持

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Efficient generation of astrocytes from human pluripotent stem cells in defined conditions.
Shaltouki A, Peng J, Liu Q, Rao MS, Zeng X.
Stem Cells, 31, 941-952 (2013)
Yiping Yan et al.
Stem cells translational medicine, 2(11), 862-870 (2013-10-12)
Human pluripotent stem cells (hPSCs), including human embryonic stem cells and human induced pluripotent stem cells, are unique cell sources for disease modeling, drug discovery screens, and cell therapy applications. The first step in producing neural lineages from hPSCs is

相关内容

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持